Analysts have raised their price target for Inogen from $11.00 to $13.00, citing updated projections of slightly stronger revenue growth and reduced discount rates as key contributors to the increased valuation.
What's in the News
- Inogen, Inc. provided new earnings guidance for the third quarter of 2025, with expected reported revenue between $91 million and $93 million. This represents approximately 4% year-over-year growth at the midpoint compared to the third quarter of 2024 (Key Developments).
- For the full year 2025, Inogen anticipates reported revenue of $354 million to $357 million. This reflects around 6% growth at the midpoint compared to 2024 (Key Developments).
Valuation Changes
- The consensus analyst price target has risen from $11.00 to $13.00, marking an increase of $2.00.
- The discount rate has decreased slightly from 7.65% to 7.55%.
- Revenue growth expectations have improved from 6.54% to 6.93%.
- The net profit margin projection has edged down from 12.49% to 12.32%.
- The future P/E ratio is expected to increase from 8.73x to 10.31x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.